ASBP - Aspire Biopharma Holdings, Inc.
1.31
-0.010 -0.763%
Share volume: 116,555
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$1.32
-0.01
-0.01%
View ratios
| Fiscal Date | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|
| Fiscal Quarter | Q1 2025 | Q3 2025 | |
| Report Date | 05-14-2025 | 11-14-2025 | |
| Assets | |||
| Total Assets | 1.966 M | 2.403 M | |
| Current Assets | 1.966 M | 2.403 M | |
| Inventories | 0.000 | 35.437 K | |
| Other Current Assets | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | |
| Current Cash | 1.347 M | 1.948 M | |
| Total Non-current Assets | 0.000 | 0.000 | |
| Property Plant Equipment | 0.000 | 0.000 | |
| Other Assets | 0.000 | 0.000 | |
| Intangible Assets | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||
| Total Liabilities and shareholders’ equity | 1.966 M | 2.403 M | |
| Total liabilities | 8.918 M | 13.870 M | |
| Total current liabilities | 8.869 M | 13.861 M | |
| Accounts Payable | 1.432 M | 1.061 M | |
| Other liabilities | 49.303 K | 9.901 K | |
| Current long term debt | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | |
| Other liabilities | 49.303 K | 9.901 K | |
| Minority interest | 0.000 | 0.000 | |
| Total Shareholder equity | -6.953 M | -11.467 M | |
| Common stock | 11.766 M | 11.083 M | |
| Retained earnings | -18.719 M | -22.550 M |